Singapore, Sept. 15 -- The Health Sciences Authority received information related to the study titled 'Beamion PANTUMOR 1: A Phase II, multicentre, multicohort, open-label trial to evaluate the effica... Read More
Singapore, Sept. 15 -- The Health Sciences Authority received information related to the study titled 'An open-label, multi-center, phase I/Ib study of IEV407 as a single agent and in combination with... Read More
Singapore, Sept. 15 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safe... Read More
U.S., Sept. 15 -- ClinicalTrials.gov registry received information related to the study (NCT07818772) titled '7T Imaging Pilot-study in Patients With Motor Neuron Disease to Find Non-Invasive Disease ... Read More
Singapore, Sept. 15 -- The Health Sciences Authority received information related to the study titled 'DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 3 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF PLOZASIRAN... Read More
Singapore, Sept. 15 -- The Health Sciences Authority received information related to the study titled 'A Phase 3 Randomized, Open-label Study of Rinatabart Sesutecan (Rina-S) versus Treatment of Inves... Read More
Singapore, Sept. 15 -- The Health Sciences Authority received information related to the study titled 'A Phase III, Randomized, Open-Label, Multicenter, Global Study of Puxitatug Samrotecan (AZD8205) ... Read More
Singapore, Sept. 15 -- The Health Sciences Authority received information related to the study titled 'A Multicenter, Randomized, Double-blind, Phase 2/3 Study of Ficerafusp Alfa (BCA101) or Placebo i... Read More
U.S., Sept. 15 -- ClinicalTrials.gov registry received information related to the study (NCT07819383) titled 'Holistic CRM Care vs Standard of Care in a Primary Care Setting' on Sept. 09. Brief Summa... Read More
Singapore, Sept. 15 -- The Health Sciences Authority received information related to the study titled 'Safety, immunogenicity and efficacy of low dose Nivolumab in adults living with HIV on antiretrov... Read More